Group items tagged

With state-of-art facilities and years of experience in the field of antigens and antibodies, Creative Diagnostics now can provide various Corynebacterium diphtheriae antigens and Corynebacterium diphtheriae proteins such as diphtheria toxin protein, C. diphtheriae diphtheria toxoid, etc.

Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A. Clin Cancer Res. 2006 Jul 1;12(13):4018-26. PMID: 16818701

The prostate is the gland below a man's bladder that produces fluid for semen. Prostate cancer is the third most common cause of death from cancer in men of all ages. It is rare in men younger than 40. Levels of a substance called prostate specific antigen (PSA) is often high in men with prostate cancer. However, PSA can also be high with other prostate conditions. Since the PSA test became common, most prostate cancers are found before they cause symptoms. Symptoms of prostate cancer may include Problems passing urine, such as pain, difficulty starting or stopping the stream, or dribbling Low back pain Pain with ejaculation Prostate cancer treatment often depends on the stage of the cancer. How fast the cancer grows and how different it is from surrounding tissue helps determine the stage. Treatment may include surgery, radiation therapy, chemotherapy or control of hormones that affect the cancer.

Scientists from Creative Biolabs have successfully built up a unique platform to develop high-affinity bovine monoclonal antibodies with ultralong CDR3s. The complementarity-determining regions (CDRs) are the most important structure part on an antibody that recognize the antigen. In humans, the specificity of an antibody is mostly governed by the largest CDR, such as CDR H3. Read full article at http://www.labslink.com/ViewResearchNews.aspx?id=9941.